

PerioTrap News
PerioTrap Pharmaceuticals, an i&i Prague Supported Start-up, Raises €3M Seed Round to Develop Selective Anti-infectives to Tackle Periodontitis
20.11.2020
Although periodontitis represents a widespread infectious disease affecting around 30% of the global population, there is no effective treatment for patients available, yet. PerioTrap Pharmaceuticals, a Fraunhofer IZI spin-off, has…
PerioTrap Pharmaceuticals, an i&i Prague Supported Start-up, Raises €3M Seed Round to Develop Selective Anti-infectives to Tackle Periodontitis
20.11.2020Although periodontitis represents a widespread infectious disease affecting around 30% of the global population, there is no effective treatment for patients available, yet. PerioTrap Pharmaceuticals, a Fraunhofer IZI spin-off, has…


LAM-X News
LAM-X, a.s. won the 2020 EIT Health #MedTech Bootcamp final #Pitch Event
18.1.2021
i&i Prague supported start-up, LAM-X, a.s., become a winner of the 2020 EIT Health…
Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020
Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
LAM-X – light-activated nanomaterials for face-masks and respirators
12.5.2020
LAM-X a.s. is the newest company established in cooperation with i&i Prague. It develops light-activated nanomaterials which provide protection from bacteria, viruses and other pathogens. The lead product is a…
LAM-X a.s. is collaborating with TUL to develop active nanofilters against COVID-19
7.5.2020
During COVID-19 crisis we embrace our startups to answer current questions and solve present problems. Our the most recently established startup – LAM-X, a.s. – is not an exception. LAM-X…
LAM-X: the newest spin-off company accelerated by i&i Prague in Czech Media
24.2.2020
Founding of LAM-X, a.s., the newest company accelerated by i&i Prague and Charles University Innovations Prague, s.r.o. was met with both interest and positive feedback from Czech national media.
LAM-X: revolutionary wound-treating nanomaterials
21.2.2020
Congratuations to LAM-X, a.s. – the newest company launched by i&i Prague! Story of LAM-X technology is a perfect example of our work in i&i…
LAM-X, a.s. won the 2020 EIT Health #MedTech Bootcamp final #Pitch Event
18.1.2021i&i Prague supported start-up, LAM-X, a.s., become a winner of the 2020 EIT Health…
Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
LAM-X – light-activated nanomaterials for face-masks and respirators
12.5.2020LAM-X a.s. is the newest company established in cooperation with i&i Prague. It develops light-activated nanomaterials which provide protection from bacteria, viruses and other pathogens. The lead product is a…
LAM-X a.s. is collaborating with TUL to develop active nanofilters against COVID-19
7.5.2020During COVID-19 crisis we embrace our startups to answer current questions and solve present problems. Our the most recently established startup – LAM-X, a.s. – is not an exception. LAM-X…
LAM-X: the newest spin-off company accelerated by i&i Prague in Czech Media
24.2.2020Founding of LAM-X, a.s., the newest company accelerated by i&i Prague and Charles University Innovations Prague, s.r.o. was met with both interest and positive feedback from Czech national media.
LAM-X: revolutionary wound-treating nanomaterials
21.2.2020Congratuations to LAM-X, a.s. – the newest company launched by i&i Prague! Story of LAM-X technology is a perfect example of our work in i&i…

Enantis News
Enantis, a Masaryk University spin-off company, concluded a license agreement for the production of stabilised growth factor FGF2.
29.1.2021
After months of negotiations, we are delighted to announce that Enantis, one of i&i Prague´s first supported start-ups, has entered into a global license…
Enantis – first biotechnology spin-off from Masaryk University in Brno
12.5.2020
Enantis s.r.o. was founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno, Czech Republic. Project went through long development and its expertise is now based…
Enantis, a Masaryk University spin-off company, concluded a license agreement for the production of stabilised growth factor FGF2.
29.1.2021After months of negotiations, we are delighted to announce that Enantis, one of i&i Prague´s first supported start-ups, has entered into a global license…
Enantis – first biotechnology spin-off from Masaryk University in Brno
12.5.2020Enantis s.r.o. was founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno, Czech Republic. Project went through long development and its expertise is now based…

Dracen Pharmaceuticals News
Dracen Pharmaceuticals Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With Advanced Solid Tumors!
13.10.2020
Pavel Majer, ÚOCHB Dracen Pharmaceuticals, Inc. has announced the start of a clinical trial of DRP-104, an anti-cancer substance developed by the team of Pavel Majer at IOCB Prague…
DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies
12.5.2020
One of the first project i&i Prague participated in is Dracen Pharmaceuticals. Dracen itself started as an international science team at the Institute of Organic Chemistry and Biochemistry (IOCB Prague)…
Dracen Pharmaceuticals Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With Advanced Solid Tumors!
13.10.2020Pavel Majer, ÚOCHB Dracen Pharmaceuticals, Inc. has announced the start of a clinical trial of DRP-104, an anti-cancer substance developed by the team of Pavel Majer at IOCB Prague…
DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies
12.5.2020One of the first project i&i Prague participated in is Dracen Pharmaceuticals. Dracen itself started as an international science team at the Institute of Organic Chemistry and Biochemistry (IOCB Prague)…

Elphogene News
Elphogene, s.r.o. received a TA CR grant for “Sample prep system and technology for cancer testing by liquid biopsy”!
21.9.2020
Elphogene, s.r.o., an i&i Prague supported start-up, just received grant from the Technology Agency of the Czech Republic (referred to as the “TA CR“) for the project “Sample prep system…
Elphogene: non-invasive screening of patients in advanced stages of cancer
12.5.2020
Elphogene s.r.o. is a Czech spin-off company that succeeds decades of intensive research performed at Genomac research centre as well as thanks to collaborations with leading oncology centres. Using their…
Elphogene – liquid biopsy assay for non-invasive monitoring of patients with colorectal cancer.
23.2.2020
Another one of successful projects supported by i&i Prague is the Prague-based biotechnological start-up Elphogene, Inc. Its oncoMonitor™, a liquid biopsy technology, was recently turned into…
Elphogene Technology in World Journal of Gastroenterology!
7.1.2020
Another great achievement for one of our projects! Prague-based biotechnological start-up Elphogene is a progressive, young company focused on monitoring of patients in advanced stages colorectal cancer. With an…
Elphogene, s.r.o. received a TA CR grant for “Sample prep system and technology for cancer testing by liquid biopsy”!
21.9.2020Elphogene, s.r.o., an i&i Prague supported start-up, just received grant from the Technology Agency of the Czech Republic (referred to as the “TA CR“) for the project “Sample prep system…
Elphogene: non-invasive screening of patients in advanced stages of cancer
12.5.2020Elphogene s.r.o. is a Czech spin-off company that succeeds decades of intensive research performed at Genomac research centre as well as thanks to collaborations with leading oncology centres. Using their…
Elphogene – liquid biopsy assay for non-invasive monitoring of patients with colorectal cancer.
23.2.2020Another one of successful projects supported by i&i Prague is the Prague-based biotechnological start-up Elphogene, Inc. Its oncoMonitor™, a liquid biopsy technology, was recently turned into…
Elphogene Technology in World Journal of Gastroenterology!
7.1.2020Another great achievement for one of our projects! Prague-based biotechnological start-up Elphogene is a progressive, young company focused on monitoring of patients in advanced stages colorectal cancer. With an…

RIOCATH News
Prague startup RIOCATH had recently entered market with its world-unique catheter!
12.5.2020
RIOCATH Global, a company established in collaboration with IOCB Tech, has developed a revolutionary type of catheter based on world-unique technology applicable for all tubular medical devices. Since its birth…
Startup Riocath is among Hello Tomorrow’s top 500 stratups in the world
1.2.2019
i&i Prague is excited to announce one of its partners, Riocath, will be featured among the top 500 deep tech startups at Hello Tomorrow’s upcoming global summit!
Prague startup RIOCATH had recently entered market with its world-unique catheter!
12.5.2020RIOCATH Global, a company established in collaboration with IOCB Tech, has developed a revolutionary type of catheter based on world-unique technology applicable for all tubular medical devices. Since its birth…
Startup Riocath is among Hello Tomorrow’s top 500 stratups in the world
1.2.2019i&i Prague is excited to announce one of its partners, Riocath, will be featured among the top 500 deep tech startups at Hello Tomorrow’s upcoming global summit!
iBodies News
License for use of iBodies® to measure free testosterone in blood bought by Immunotech, a member of the Beckman Coulter group!
11.8.2020
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague), the Institute of Macromolecular Chemistry of the Czech Academy of Sciences (IMC), and Charles University…
iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity, Cancer Research UK
22.6.2020
Project iBodies, supported by IOCB Tech and i&i Prague, is focused on developing novel macromolecules designed to fully substitute antibodies in common biochemical methods. Recently, iBodies established a cooperation…
iBodies – synthetic antibodies from IOCB
12.5.2020
iBodies is a project originated at IMC, IOCB and Charles University, which is currently under a pre-seed incubation. The iBodies team focuses on development of the novel…
Novel partnership for iBodies has been facilitated by i&i Prague and IOCB Tech managers
20.10.2018
The Institute of Macromolecular Chemistry (IMC) in cooperation with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) started novel collaborative project with the International Cannabis and Cannabinoids Institute (ICCI). The project deals with a development of a novel synthetic antibody mimetics called iBodies® for clinical diagnostic.
License for use of iBodies® to measure free testosterone in blood bought by Immunotech, a member of the Beckman Coulter group!
11.8.2020The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague), the Institute of Macromolecular Chemistry of the Czech Academy of Sciences (IMC), and Charles University…
iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity, Cancer Research UK
22.6.2020Project iBodies, supported by IOCB Tech and i&i Prague, is focused on developing novel macromolecules designed to fully substitute antibodies in common biochemical methods. Recently, iBodies established a cooperation…
iBodies – synthetic antibodies from IOCB
12.5.2020iBodies is a project originated at IMC, IOCB and Charles University, which is currently under a pre-seed incubation. The iBodies team focuses on development of the novel…
Novel partnership for iBodies has been facilitated by i&i Prague and IOCB Tech managers
20.10.2018The Institute of Macromolecular Chemistry (IMC) in cooperation with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) started novel collaborative project with the International Cannabis and Cannabinoids Institute (ICCI). The project deals with a development of a novel synthetic antibody mimetics called iBodies® for clinical diagnostic.

Diana Biotechnologies News
Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020
Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
DIANA Biotechnologies – technology that raised EUR 3M in 3 years
12.5.2020
DIANA Biotechnologies started as a project of a PhD. student at IOCB. After less than 3 years of pre-seed incubation it developed into an independent biotech company, with their own…
Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
DIANA Biotechnologies – technology that raised EUR 3M in 3 years
12.5.2020DIANA Biotechnologies started as a project of a PhD. student at IOCB. After less than 3 years of pre-seed incubation it developed into an independent biotech company, with their own…
News
Enantis, a Masaryk University spin-off company, concluded a license agreement for the production of stabilised growth factor FGF2.
29.1.2021After months of negotiations, we are delighted to announce that Enantis, one of i&i Prague´s first supported start-ups, has entered into a global license…
LAM-X, a.s. won the 2020 EIT Health #MedTech Bootcamp final #Pitch Event
18.1.2021i&i Prague supported start-up, LAM-X, a.s., become a winner of the 2020 EIT Health…
Learn more about CasInvent Pharma, a.s., an university spin-off developing leukaemia treatment!
6.1.2021Don´t miss this interesting report on ČT24 about the newest Masaryk University spin-off: CasInvent Pharma, a.s.! With the support of…
CasInvent Pharma, a New University Spin-Off Focused on Developing Cancer Drugs Established with Help of i&i Prague!
16.12.2020A new spin-off company, CasInvent Pharma, a.s., has been established by Masaryk University (MU) in cooperation with its investment partner, i&i Prague, s.r.o. (Ltd), in order to facilitate further development…
PerioTrap Pharmaceuticals, an i&i Prague Supported Start-up, Raises €3M Seed Round to Develop Selective Anti-infectives to Tackle Periodontitis
20.11.2020Although periodontitis represents a widespread infectious disease affecting around 30% of the global population, there is no effective treatment for patients available, yet. PerioTrap Pharmaceuticals, a Fraunhofer IZI spin-off, has…